Isoform separation and structural identification of mono-PEGylated recombinant human growth hormone (PEG-rhGH) with pH gradient chromatography.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

• Publication date

  2017-02-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jchromb.2016.12.014PMID 28153672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs.

  2016cited by this paper
• Feasibility of poly(ethylene glycol) derivatives as diagnostic drug carriers for tumor imaging.

  2016cited by this paper
• Site-Specific PEGylation of Therapeutic Proteins

  2015cited by this paper
• Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone.

  2014cited by this paper
• Determination of the molecular weight of poly(ethylene glycol) in biological samples by reversed-phase LC–MS with in-source fragmentation

  2013cited by this paper
• Production, purification and biological characterization of mono-PEGylated anti-IL-17A antibody fragments.

  2013cited by this paper
• Systematic generation of buffer systems for pH gradient ion exchange chromatography and their application.

  2013cited by this paper
• Chemical and enzymatic site specific PEGylation of hGH.

  2013cited by this paper
• Isoform separation and binding site determination of mono-PEGylated lysozyme with pH gradient chromatography.

  2012cited by this paper
• FDA-approved poly(ethylene glycol)–protein conjugate drugs

  2011cited by this paper
• Effects of PEG size on structure, function and stability of PEGylated BSA.

  2011cited by this paper
• PEGylated recombinant von Willebrand factor analyzed by means of MALDI-TOF-MS, CGE-on-a-chip and nES-GEMMA

  2011cited by this paper
• Enhanced circulation half-life of site-specific PEGylated rhG-CSF: optimization of PEG molecular weight.

  2009cited by this paper
• PEGylation of somatropin (recombinant human growth hormone): Impact on its clearance in humans

  2008cited by this paper
• PEGylation: Posttranslational bioengineering of protein biotherapeutics.

  2008cited by this paper
• Solid-phase PEGylation of recombinant interferon alpha-2a for site-specific modification: process performance, characterization, and in vitro bioactivity.

  2007cited by this paper
• pH-gradient ion-exchange chromatography: an analytical tool for design and optimization of protein separations.

  2007cited by this paper
• Comparison of strong anion-exchangers for the purification of a PEGylated protein.

  2007cited by this paper
• A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats.

  2007cited by this paper
• Modulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study

  2006cited by this paper
• The design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta).

  2004cited by this paper
• Effective drug delivery by PEGylated drug conjugates.

  2003cited by this paper
• Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon alpha-2a (PEGASYS).

  2003cited by this paper
• Preparation and Characterization of Mono-PEGylated Epidermal Growth Factor: Evaluation of in Vitro Biologic Activity

  2002cited by this paper
• Identification of the modifying sites of mono-PEGylated salmon calcitonins by capillary electrophoresis and MALDI-TOF mass spectrometry.

  2001cited by this paper
• GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils.

  2001cited by this paper
• Long-acting Growth Hormones Produced by Conjugation with Polyethylene Glycol*

  1996cited by this paper
• Characterization and Stability of N-terminally PEGylated rhG-CSF

  1996cited by this paper
• Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.

  1977cited by this paper

• A Reporter Gene Assay for Measuring the Biological Activity of PEGylated Recombinant Human Growth Hormone

  2025cites this paper
• Site-specific PEGylation of proteins: Insights into structural and functional changes

  2025cites this paper
• Positional isoform analysis of PEGylated biotherapeutic protein using a novel peptide-based reversed-phase liquid chromatography with UV detection.

  2025cites this paper
• Long-term Pegylated GH for Children With GH Deficiency: A Large, Prospective, Real-world Study

  2023cites this paper
• A monolithic stationary phase with dendritic nanostructures for the separation of PEGylated proteins

  2023cites this paper
• Reversed-phase pH gradient thin-layer chromatography of biologically active substances with controlled developing solvent velocity.

  2021cites this paper
• Interpol review of controlled substances 2016–2019☆

  2020cites this paper
• From Synthesis to Characterization of Site-Selective PEGylated Proteins

  2019cites this paper
• Progress and Challenges in PEGylated Proteins Downstream Processing: A Review of the Last 8 Years

  2019cites this paper